Cardiovascular Outcomes of Treatment with Febuxostat and Allopurinol in Gout Patients with Kidney Disease

被引：0
|
作者：
White, William B. [1 ]
Gunawardhana, Lhanoo [2 ]
机构：
[1] Univ Connecticut, Sch Med, Cardiol, Farmington, CT USA
[2] Takeda Pharmaceut Int, Deerfield, IL USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2242
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment
    Vargas-Santos, Ana Beatriz
    Peloquin, Christine E.
    Zhang, Yuqing
    Neogi, Tuhina
    JAMA INTERNAL MEDICINE, 2018, 178 (11) : 1526 - 1533
  • [42] Febuxostat a new drug for treatment of gout. Increased cardiovascular risk in gout patients?
    Christalla, P.
    Wittkoepper, K.
    El-Armouche, A.
    KARDIOLOGE, 2011, 5 (01): : 45 - 49
  • [43] Comparison of uric acid reduction and renal outcomes of febuxostat vs allopurinol in patients with chronic kidney disease
    Yueh-Lung Peng
    You-Lin Tain
    Chien-Te Lee
    Yi-Hsn Yang
    Yaw-Bin Huang
    Yen-Hsia Wen
    Chien-Ning Hsu
    Scientific Reports, 10
  • [44] Cardiovascular risk associated with allopurinol or benzbromarone treatment in patients with gout
    Eun, Yeonghee
    Han, Heewon
    Kim, Kyunga
    Kang, Seonyoung
    Lee, Seulkee
    Kim, Hyungjin
    Lee, Jaejoon
    Koh, Eun-Mi
    Cha, Hoon-Suk
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [45] CARDIOVASCULAR RISK ASSOCIATED WITH TREATMENT OF ALLOPURINOL AND BENZBROMARONE IN PATIENTS WITH GOUT
    Eun, Y.
    Kang, S. Y.
    Lee, S.
    Kim, H.
    Lee, J.
    Koh, E. M.
    Cha, H. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 280 - 281
  • [46] A STUDY OF ALLOPURINOL USE IN PATIENTS WITH GOUT AND CHRONIC KIDNEY DISEASE
    Sukhdeo, A.
    Sturgess, A.
    INTERNAL MEDICINE JOURNAL, 2014, 44 : 11 - 12
  • [47] Cardiovascular Risk Associated with Treatment of Allopurinol and Benzbromarone in Patients with Gout
    Eun, Yeonghee
    Kang, Seonyoung
    Lee, Seulkee
    Kim, Hyungjin
    Lee, Jaejoon
    Koh, Eun-Mi
    Cha, Hoon-Suk
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1379 - 1380
  • [48] FEBUXOSTAT MAY BE USEFULLY UTILIZED FOR ALLOPURINOL-REFRACTORY HYPERURICEMIA IN GOUT TREATMENT OF DIALYSIS PATIENTS OR THOSE IN STAGE 4 CHRONIC KIDNEY DISEASE ( CKD)
    Son, C. -N.
    Jeong, H. -J.
    Kim, J. -M.
    Kim, H. -S.
    Kim, S. -H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 538 - 538
  • [49] Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study
    Kang, Eun Ha
    Choi, Hyon K.
    Shin, Anna
    Lee, Yun Jong
    Lee, Eun Bong
    Song, Yeong Wook
    Kim, Seoyoung C.
    RHEUMATOLOGY, 2019, 58 (12) : 2122 - 2129
  • [50] Cardiovascular Safety of Febuxostat in Patients With Gout or Hyperuricemia
    Ghossan, Roba
    Tabesh, Ouidade Aitisha
    Fayad, Fouad
    Richette, Pascal
    Bardin, Thomas
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2024, 30 (02) : e46 - e53
12345